NUMARK LABS INC
Drug class
Iron
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products. Read more about Iron
368 drugs in this class 107 manufacturers
Drugs in Iron
FERRETTS IPS (iron succinyl-protein complex)
IRON · IRON DEFICIENCY ANEMIA
PHARMICS
OBSTETRIX EC (prenatal vitamins no.127/iron,carbonyl/folic acid/docusate)
FOLIC ACID · PREGNANCY ·+1
SEYER INC.
FERREX 150 PLUS (iron asp gly,ps cmplx/ascorb calcium/Ca-thr/succinic acid)
IRON · IRON DEFICIENCY ANEMIA
BRECKENRIDGE
VITAFOL-OB+DHA (prenatal vits with calcium no.10/ferrous fum/folic acid/dha)
FOLIC ACID · PREGNANCY ·+1
Everett Laboratories
NANO VM 1-3 (pediatric multivitamin no.14/ferrous fumarate/folic acid)
FOLIC ACID · VITAMIN DEFICIENCY ·+3
SOLACE NUTRITIO
NANO VM 4-8 (pediatric multivitamin no.15/ferrous fumarate/folic acid)
FOLIC ACID · VITAMIN DEFICIENCY ·+3
SOLACE NUTRITIO
PRO FE (iron polysaccharide complex)
IRON · IRON DEFICIENCY ANEMIA
PRO-PHARMA LLC
BRECKENRIDGE
Filter & compare in the drug finder →
Opens the drug finder with Iron preselected. Add indication or manufacturer filters there.
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products.
These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body.
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand.
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure.
-
fda.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body
-
fda.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products
-
nih.gov
The term iron typically refers to the essential trace mineral rather than an isolated pharmacological drug class; however, in therapeutic classifications by regulatory agencies and biomedical compendia, therapeutic iron formulations are recognized under the class of hematinics or iron replacement products
-
fda.gov
These agents function by replenishing depleted systemic iron stores to support normal erythropoiesis, hemoglobin synthesis, cellular energy metabolism, and oxygen transport throughout the body
-
nih.gov
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand
-
nih.gov
They are principally indicated for the prevention and treatment of iron deficiency and iron deficiency anemia resulting from chronic blood loss, malnutrition, malabsorption, pregnancy, or increased demand
-
fda.gov
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure
-
nih.gov
Additionally, parenteral iron formulations are widely utilized to manage iron deficiency in specialized clinical disease states, notably chronic kidney disease (often in patients undergoing hemodialysis or receiving erythropoiesis-stimulating agents) and heart failure
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.